Abstract:Objective: To investigate the safety and effects of pitavastatin-loaded nanoparticles eluting stent in percutaneous coronary artery stent implantation in experimental porcine models. Methods: The authors developed a novel drug eluting stent (DES) by using nanoparticles, which was made of biological absorbable FLGA material that could be coated on stent by using positive ion electroplating and coating technology. First, the human smooth muscle cells obtained from coronary artery and the human umbilical vein endothelial cells were cultured in vitro to observe the effects of statins on the cellular proliferation, which was compared with the effects of rapamycin and paclitaxel. The effects of statins-loaded nanoparticle eluting stent on intima proliferation and endothelial regeneration were then studied in vivo in experimental porcine by percutaneous coronary artery stent implantation. Results: The FLAG nanoparticles labeled by FITC were homogeneously coated on the stent by positive ion electroplating and coating technology. The results of in vitro experiment showed that approximately 40% of FITC was released from the nanoparticles within 24 hours, and all the rest was completely released after 30 days. FITC labeled nanoparticles were completely released from coating stent after 56 days. The results of in vitro experiment showed that statins could inhibit the proliferation of smooth muscle cells, but the pitavastatin exhibited the strongest inhibition effect compared with simvastatin, fluvastatin and atorvastatin (P < 0.001). Among the drugs tested, pitavastatin was the only drug that could promote the endothelial cell regeneration (P < 0.05). Moreover, pitavastatin could exert its inhibitory effect even at the concentration as low as 0.01 μmol/L (P < 0.05). Therefore, pitavastatin was used to test the biological effect in vivo by employing statin nanoparticle coated DES in coronary artery stent implantation. The results indicate d that pitavastatin nanoparticle loaded DES could significantly reduce the intima proliferation when compared with non-drugloaded nanoparticle DES (P < 0.01). The degree of intima proliferation seen in pitavastatin nanoparticle loaded DES was quite the same as seen in Cypher stent (P > 0.05). Moreover, the inflammation, fibrosis and endothelial cell regeneration seen in pitavastatin nanoparticle loaded DES were also markedly reduced (P < 0.01). Conclusion: The pitavastatin loaded nanoparticle DES has been successfully developed. The use of this new pitavastatin loaded nanoparticle DES can significantly reduce the incidence of in-stent re-stenosis and thrombosis.

Safety and Efficacy of a Novel Plastic Stent Coated with Stone-Dissolving Agents for the Treatment of Biliary Stones in a Porcine Model

The Effect Of A Novel Drug-Eluting Plastic Stent On Biliary Stone Dissolution In An Ex Vivo Bile Perfusion Model

A Prospective Study of the Efficacy of Endoscopic Biliary Stenting on Common Bile Duct Stones

Drug-eluting Fully Covered Self-Expanding Metal Stent for Dissolution of Bile Duct Stones in Vitro

Experimental Study of 103pd Stents for Preventing the Restenosis of Biliary Duct

Feasibility of biodegradable PLGA common bile duct stents: An in vitro and in vivo study

Fabrication And Characterization Of Metal Stent Coating With Drug-Loaded Nanofiber Film For Gallstone Dissolution

Treatment for Difficult Common Bile Duct Stones by Endoscopic Retrograde Biliary Plastic Stent Placement Drainage

Preventive effect of biodegradable stents on biliary stricture and fibrosis after biliary anastomosis in a porcine model

A novel biodegradable polymer coated,sirolimus-eluting stent: evaluation in a porcine coronary model

A novel biodegradable polymer-coated cobalt-chromium alloy sirolimus-eluting stent：evaluation in a porcine model

A Biodegradable-Polymer-plga-coated,sirolimus-eluting Cobalt-chromium Alloy Stent:Safety and Efficacy Evaluation in a Porcine Model

Biosynthetic Plastics as Tunable Elastic and Visible Stent with Shape‐Memory to Treat Biliary Stricture

Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs

Safety of a novel biodegradable stent implanted in the coronary artery in a porcine model

Polymer-free Dual Drug-Eluting Stents Evaluated in a Porcine Model

Clinical research of biliary plastic stenting combined with ursodeoxycholic acid in elderly patients with unextractable common bile duct stones

Improvement of Hydrophilicity and Formation of Heparin/chitosan Coating Inhibits Stone Formation in Ureteral Stents

Study of Biodegradable and Self-Expandable PLLA Helical Biliary Stent in Vivo and in Vitro

The preparation of pitavastatin incorporated nanoparticle-eluting stent

Evaluation of a Novel Paclitaxel-Eluting Stent with a Bioabsorbable Polymeric Surface Coating in the Porcine Artery Injury Model